News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
The U.S. Food and Drug Administration will now require COVID-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart ...
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...
Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated ...
The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback